Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

IOVAIOVANCE BIOTHERAPEUTICS, INC.

Nasdaq · CIK 0001425205
Filer categoryAccelerated filer
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts405

Identity from submissions API

NameIOVANCE BIOTHERAPEUTICS, INC.
CIK0001425205
TickersIOVA
ExchangesNasdaq
Entity typeoperating
CategoryAccelerated filer
SIC2836 Biological Products, (No Diagnostic Substances)
EIN753254381
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone6502607120
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Lion Biotechnologies, Inc. (2013-10-23T04:00:00.000Z → 2017-06-05T04:00:00.000Z)
  • Genesis Biopharma, Inc (2010-03-19T04:00:00.000Z → 2013-09-23T04:00:00.000Z)
  • FREIGHT MANAGEMENT CORP (2008-01-29T05:00:00.000Z → 2010-03-08T05:00:00.000Z)
Business address
825 INDUSTRIAL ROAD
4TH FLOOR
SAN CARLOS
CA
94070
CA
Mailing address
825 INDUSTRIAL ROAD
4TH FLOOR
SAN CARLOS
CA
94070
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

1050 filing rows loaded from submissions recent; extra archives: CIK0001425205-submissions-001.json (50 filings, 2008-01-29 to 2010-11-14).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-13 4 OWNERSHIP DOCUMENT 0001104659-26-127199 10153
2026-11-12 4 OWNERSHIP DOCUMENT 0001104659-26-126319 9804
2026-11-10 4 OWNERSHIP DOCUMENT 0001104659-26-125318 9800
2026-11-10 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000093751-26-000677 005-85384 261538084 34 8401
2026-11-05 8-K 8-K 8.01,9.01 0001193125-26-450084 001-36860 261528289 34 19297445 1 1
2026-11-05 10-Q 10-Q 0001193125-26-448809 001-36860 261525151 34 15936582 1 1
2026-11-05 8-K FORM 8-K 2.02,9.01 0001104659-26-123030 001-36860 261524715 34 299956 1 1
2026-10-29 8-K FORM 8-K 8.01,9.01 0001104659-26-120261 001-36860 261502701 34 233481 1 1
2026-10-05 8-K FORM 8-K 8.01,9.01 0001104659-26-113763 001-36860 261441236 34 21873291 1 1
2026-10-02 4 OWNERSHIP DOCUMENT 0001104659-26-113342 11192
2026-10-02 3 OWNERSHIP DOCUMENT 0001104659-26-113341 3600
2026-09-29 8-K FORM 8-K 8.01,9.01 0001104659-26-111583 001-36860 261419123 34 255727 1 1
2026-09-10 4 OWNERSHIP DOCUMENT 0001104659-26-106752 9787
2026-09-10 4 OWNERSHIP DOCUMENT 0001104659-26-106750 9806
2026-09-10 4 OWNERSHIP DOCUMENT 0001104659-26-106748 9774
2026-09-03 4 OWNERSHIP DOCUMENT 0001104659-26-105101 9788
2026-09-03 4 OWNERSHIP DOCUMENT 0001104659-26-105100 9774
2026-09-03 4 OWNERSHIP DOCUMENT 0001104659-26-105099 9806
2026-08-12 4 OWNERSHIP DOCUMENT 0001104659-26-095040 9817
2026-08-10 4 OWNERSHIP DOCUMENT 0001104659-26-093482 9815
2026-08-07 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000093751-26-000486 005-85384 261251962 34 8430
2026-08-06 8-K FORM 8-K 8.01,9.01 0001104659-26-092145 001-36860 261250568 34 7621268 1 1
2026-08-06 10-Q 10-Q 0001104659-26-091716 001-36860 261246646 34 11274910 1 1
2026-08-06 8-K FORM 8-K 2.02,9.01 0001104659-26-091619 001-36860 261245908 34 309101 1 1
2026-07-28 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-002600 005-85384 261212624 34 11493
2026-07-02 8-K FORM 8-K 8.01,9.01 0001104659-26-080409 001-36860 261152735 34 7306188 1 1
2026-06-18 4 OWNERSHIP DOCUMENT 0001104659-26-075863 6661
2026-06-18 4 OWNERSHIP DOCUMENT 0001104659-26-075861 6658
2026-06-18 4 OWNERSHIP DOCUMENT 0001104659-26-075858 6672
2026-06-18 4 OWNERSHIP DOCUMENT 0001104659-26-075856 6659
2026-06-18 4 OWNERSHIP DOCUMENT 0001104659-26-075854 6311
2026-06-18 S-8 FORM S-8 0001104659-26-075832 333-296916 261103888 33 279189 1 1
2026-06-18 S-8 FORM S-8 0001104659-26-075831 333-296915 261103883 33 300222 1 1
2026-06-18 S-3ASR S-3ASR 0001104659-26-075778 333-296908 261103237 33 1698000 1 1
2026-06-10 8-K FORM 8-K 5.07,8.01,9.01 0001104659-26-072408 001-36860 261080507 34 236989 1 1
2026-06-09 4 OWNERSHIP DOCUMENT 0001104659-26-071899 9788
2026-06-09 4 OWNERSHIP DOCUMENT 0001104659-26-071897 9827
2026-06-09 4 OWNERSHIP DOCUMENT 0001104659-26-071895 9774
2026-06-09 4 OWNERSHIP DOCUMENT 0001104659-26-071891 9806
2026-06-03 4 OWNERSHIP DOCUMENT 0001104659-26-070155 9789
2026-06-03 4 OWNERSHIP DOCUMENT 0001104659-26-070153 9774
2026-06-03 4 OWNERSHIP DOCUMENT 0001104659-26-070152 9827
2026-06-03 4 OWNERSHIP DOCUMENT 0001104659-26-070149 9806
2026-05-13 4 OWNERSHIP DOCUMENT 0001104659-26-060356 9816
2026-05-12 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000093751-26-000249 005-85384 26966711 34 8429
2026-05-07 8-K FORM 8-K 2.02,9.01 0001104659-26-056782 001-36860 26951209 34 286044 1 1
2026-05-07 10-Q 10-Q 0001104659-26-056778 001-36860 26951204 34 9638871 1 1
2026-05-01 ARS ARS 0001104659-26-054229 001-36860 26933604 34 7655644
2026-04-28 DEFA14A DEFA14A 0001104659-26-050467 001-36860 26909069 34 431451
2026-04-28 DEF 14A DEF 14A 0001104659-26-050458 001-36860 26909012 34 3800567 1 1
2026-04-17 PRE 14A PRE 14A 0001104659-26-044958 001-36860 26872491 34 3801275 1 1
2026-03-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-001540 005-85384 26801656 34 7503
2026-03-20 8-K FORM 8-K 5.02 0001104659-26-032774 001-36860 26778985 34 189058 1 1
2026-03-11 4 OWNERSHIP DOCUMENT 0001104659-26-026475 6212
2026-03-11 4 OWNERSHIP DOCUMENT 0001104659-26-026457 6189
2026-03-11 4 OWNERSHIP DOCUMENT 0001104659-26-026451 6175
2026-03-11 4 OWNERSHIP DOCUMENT 0001104659-26-026448 6225
2026-03-11 4 OWNERSHIP DOCUMENT 0001104659-26-026444 6211
2026-03-11 4 OWNERSHIP DOCUMENT 0001104659-26-026442 6211
2026-03-06 4 OWNERSHIP DOCUMENT 0001104659-26-024765 9650
2026-03-06 4 OWNERSHIP DOCUMENT 0001104659-26-024762 9692
2026-03-06 4 OWNERSHIP DOCUMENT 0001104659-26-024760 9639
2026-03-06 4 OWNERSHIP DOCUMENT 0001104659-26-024759 9671
2026-03-04 4 OWNERSHIP DOCUMENT 0001104659-26-023539 11996
2026-03-04 4 OWNERSHIP DOCUMENT 0001104659-26-023538 12012
2026-03-04 4 OWNERSHIP DOCUMENT 0001104659-26-023537 9635
2026-03-04 4 OWNERSHIP DOCUMENT 0001104659-26-023535 12033
2026-02-26 4 OWNERSHIP DOCUMENT 0001104659-26-020613 9951
2026-02-24 10-K 10-K 0001104659-26-018899 001-36860 26667889 34 13556359 1 1
2026-02-24 8-K FORM 8-K 2.02,8.01,9.01 0001104659-26-018837 001-36860 26667595 34 9152373 1 1
2026-02-12 4 OWNERSHIP DOCUMENT 0001104659-26-014400 9677
2026-02-09 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000093751-26-000057 005-85384 26609551 34 8322
2026-01-09 8-K FORM 8-K 8.01,9.01 0001104659-26-002323 001-36860 26521364 34 8082371 1 1
2025-12-03 4 OWNERSHIP DOCUMENT 0001104659-25-118170 15110
2025-12-03 4 OWNERSHIP DOCUMENT 0001104659-25-118169 15089
2025-12-03 4 OWNERSHIP DOCUMENT 0001104659-25-118168 15076
2025-12-03 4 OWNERSHIP DOCUMENT 0001104659-25-118167 9637
2025-11-12 S-8 S-8 0001104659-25-110496 333-291475 251474021 33 176659 1 1
2025-11-12 S-8 S-8 0001104659-25-110493 333-291474 251474008 33 183188 1 1
2025-11-06 10-Q 10-Q 0001104659-25-107470 001-36860 251456551 34 11839742 1 1
2025-11-06 8-K FORM 8-K 2.02,9.01 0001104659-25-107426 001-36860 251456275 34 288156 1 1
2025-09-04 4 OWNERSHIP DOCUMENT 0001104659-25-087549 12002
2025-09-04 4 OWNERSHIP DOCUMENT 0001104659-25-087547 9637
2025-09-04 4 OWNERSHIP DOCUMENT 0001104659-25-087546 12038
2025-09-04 4 OWNERSHIP DOCUMENT 0001104659-25-087545 12016
2025-08-29 8-K FORM 8-K 8.01,9.01 0001104659-25-085650 001-36860 251280869 34 7484909 1 1
2025-08-22 8-K FORM 8-K 1.01,9.01 0001104659-25-081953 001-36860 251247212 34 497205 1 1
2025-08-22 424B5 424B5 0001104659-25-081949 333-272718 251247183 33 613310 1 1
2025-08-19 8-K FORM 8-K 8.01,9.01 0001104659-25-080304 001-36860 251232536 34 221348 1 1
2025-08-08 4 OWNERSHIP DOCUMENT 0001104659-25-075687 8412
2025-08-08 3 OWNERSHIP DOCUMENT 0001104659-25-075679 3496
2025-08-07 10-Q 10-Q 0001558370-25-010807 001-36860 251195336 34 11902665 1 1
2025-08-07 8-K FORM 8-K 2.02,5.02,9.01 0001104659-25-075175 001-36860 251193936 34 308883 1 1
2025-07-29 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000932471-25-000911 005-85384 251160153 34 6548
2025-07-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-003200 005-85384 251132409 34 11404
2025-07-15 8-K FORM 8-K 5.02,8.01,9.01 0001104659-25-067940 001-36860 251123087 34 232912 1 1
2025-07-10 3 OWNERSHIP DOCUMENT 0001104659-25-066983 9528
2025-07-03 8-K FORM 8-K 5.02 0001104659-25-065781 001-36860 251105583 34 192408 1 1
2025-06-17 4 OWNERSHIP DOCUMENT 0001104659-25-060254 6533
2025-06-17 4 OWNERSHIP DOCUMENT 0001104659-25-060253 6516
2025-06-17 4 OWNERSHIP DOCUMENT 0001104659-25-060251 6499
2025-06-17 4 OWNERSHIP DOCUMENT 0001104659-25-060249 6474
2025-06-17 4 OWNERSHIP DOCUMENT 0001104659-25-060245 6366
2025-06-13 8-K FORM 8-K 5.02 0001104659-25-059464 001-36860 251047693 34 188324 1 1
2025-06-10 8-K FORM 8-K 5.07 0001104659-25-058199 001-36860 251038014 34 205274 1 1
2025-06-06 4 OWNERSHIP DOCUMENT 0001104659-25-057310 5323
2025-06-04 4 OWNERSHIP DOCUMENT 0001104659-25-056444 9637
2025-06-04 4 OWNERSHIP DOCUMENT 0001104659-25-056440 12002
2025-06-04 4 OWNERSHIP DOCUMENT 0001104659-25-056438 12038
2025-06-04 4 OWNERSHIP DOCUMENT 0001104659-25-056437 12016
2025-06-04 4 OWNERSHIP DOCUMENT 0001104659-25-056432 9919
2025-05-27 4 OWNERSHIP DOCUMENT 0001104659-25-052968 5288
2025-05-16 4 OWNERSHIP DOCUMENT 0001104659-25-049999 5303
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-072720 005-85384 25954047 34 11116
2025-05-08 10-Q 10-Q 0001558370-25-007009 001-36860 25927404 34 10020723 1 1
2025-05-08 8-K FORM 8-K 2.02,9.01 0001104659-25-046101 001-36860 25925938 34 298280 1 1
2025-04-30 ARS ARS 0001558370-25-006019 001-36860 25896610 34 4939333
2025-04-28 DEFA14A DEFA14A 0001558370-25-005704 001-36860 25881451 34 405059
2025-04-28 DEF 14A DEF 14A 0001558370-25-005702 001-36860 25881373 34 4125936 1 1
2025-03-18 4 OWNERSHIP DOCUMENT 0001104659-25-025216 9639
2025-03-07 4 OWNERSHIP DOCUMENT 0001104659-25-021872 6197
2025-03-07 4 OWNERSHIP DOCUMENT 0001104659-25-021871 6182
2025-03-07 4 OWNERSHIP DOCUMENT 0001104659-25-021869 6232
2025-03-07 4 OWNERSHIP DOCUMENT 0001104659-25-021868 6215
2025-03-07 4 OWNERSHIP DOCUMENT 0001104659-25-021866 6240
2025-03-05 4 OWNERSHIP DOCUMENT 0001104659-25-021062 9928
2025-03-05 4 OWNERSHIP DOCUMENT 0001104659-25-021058 12025
2025-03-05 4 OWNERSHIP DOCUMENT 0001104659-25-021057 12010
2025-03-05 4 OWNERSHIP DOCUMENT 0001104659-25-021056 9646
2025-03-05 4 OWNERSHIP DOCUMENT 0001104659-25-021055 12046
2025-02-27 10-K 10-K 0001558370-25-001834 001-36860 25680685 34 13839665 1 1
2025-02-27 8-K FORM 8-K 2.02,9.01 0001104659-25-018212 001-36860 25678655 34 329692 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-021219 005-85384 25628904 34 11030
2025-02-12 4 OWNERSHIP DOCUMENT 0001104659-25-012273 11107
2025-02-12 3 OWNERSHIP DOCUMENT 0001104659-25-012271 3535
2025-02-10 8-K FORM 8-K 8.01,9.01 0001104659-25-010729 001-36860 25603652 34 238727 1 1
2025-01-16 4 OWNERSHIP DOCUMENT 0001104659-25-004205 9654
2025-01-16 4 OWNERSHIP DOCUMENT 0001104659-25-004204 9692
2025-01-16 4 OWNERSHIP DOCUMENT 0001104659-25-004202 9671
2024-12-18 4 OWNERSHIP DOCUMENT 0001104659-24-129814 9644
2024-12-13 S-8 FORM S-8 0001104659-24-128516 333-283825 241549373 33 308792 1 1
2024-12-04 4 OWNERSHIP DOCUMENT 0001104659-24-125547 9657
2024-12-04 4 OWNERSHIP DOCUMENT 0001104659-24-125544 9674
2024-12-04 4 OWNERSHIP DOCUMENT 0001104659-24-125542 9695
2024-12-02 3 OWNERSHIP DOCUMENT 0001104659-24-124712 9258
2024-11-21 8-K FORM 8-K 1.01,1.02 0001104659-24-121612 001-36860 241485503 34 203682 1 1
2024-11-14 4 OWNERSHIP DOCUMENT 0001104659-24-119195 9650
2024-11-14 SC 13G/A SC 13G/A 0001193125-24-258737 005-85384 241463741 34 57832
2024-11-12 144 xsl144X01/primary_doc.xml 0001104659-24-117019 001-36860 241450594 33 4722
2024-11-08 8-K FORM 8-K 8.01,9.01 0001104659-24-115444 001-36860 241437728 34 7959432 1 1
2024-11-07 10-Q 10-Q 0001558370-24-014905 001-36860 241437071 34 10790209 1 1
2024-11-07 8-K FORM 8-K 2.02,9.01 0001104659-24-115300 001-36860 241435560 34 311999 1 1
2024-10-18 SC 13G/A Iovance_Biothera_Inc.htm 0000093751-24-000848 005-85384 241378941 34 56342
2024-10-16 4 OWNERSHIP DOCUMENT 0001104659-24-109279 9660
2024-10-16 4 OWNERSHIP DOCUMENT 0001104659-24-109277 9697
2024-10-16 4 OWNERSHIP DOCUMENT 0001104659-24-109272 9676
2024-09-05 4 OWNERSHIP DOCUMENT 0001104659-24-097491 15232
2024-09-05 4 OWNERSHIP DOCUMENT 0001104659-24-097490 15264
2024-09-05 4 OWNERSHIP DOCUMENT 0001104659-24-097488 15247
2024-09-05 4 OWNERSHIP DOCUMENT 0001104659-24-097487 9980
2024-08-09 8-K FORM 8-K 8.01,9.01 0001104659-24-087876 001-36860 241193995 34 8851600 1 1
2024-08-09 S-8 FORM S-8 0001104659-24-087391 333-281413 241189866 33 184263 1 1
2024-08-09 S-8 FORM S-8 0001104659-24-087388 333-281412 241189859 33 187308 1 1
2024-08-08 10-Q 10-Q 0001558370-24-011641 001-36860 241189582 34 11032851 1 1
2024-08-08 8-K FORM 8-K 2.02,9.01 0001104659-24-087259 001-36860 241188172 34 318111 1 1
2024-07-17 4 OWNERSHIP DOCUMENT 0001104659-24-080619 9660
2024-07-17 4 OWNERSHIP DOCUMENT 0001104659-24-080617 9697
2024-07-17 4 OWNERSHIP DOCUMENT 0001104659-24-080616 9676
2024-06-28 8-K FORM 8-K 8.01,9.01 0001104659-24-075997 001-36860 241081371 34 226403 1 1
2024-06-13 4 OWNERSHIP DOCUMENT 0001104659-24-071374 6540
2024-06-13 4 OWNERSHIP DOCUMENT 0001104659-24-071373 6373
2024-06-13 4 OWNERSHIP DOCUMENT 0001104659-24-071372 6506
2024-06-13 4 OWNERSHIP DOCUMENT 0001104659-24-071370 6523
2024-06-13 4 OWNERSHIP DOCUMENT 0001104659-24-071368 6478
2024-06-11 8-K FORM 8-K 5.07 0001104659-24-070470 001-36860 241036728 34 214851 1 1
2024-06-05 4 OWNERSHIP DOCUMENT 0001104659-24-068773 9695
2024-06-05 4 OWNERSHIP DOCUMENT 0001104659-24-068772 9674
2024-06-05 4 OWNERSHIP DOCUMENT 0001104659-24-068771 9657
2024-06-03 8-K FORM 8-K 8.01,9.01 0001104659-24-067485 001-36860 241012029 34 10420489 1 1
2024-05-24 8-K FORM 8-K 8.01,9.01 0001104659-24-064825 001-36860 24980483 34 232314 1 1
2024-05-17 DEFA14A DEFA14A 0001104659-24-063094 001-36860 24961309 34 27536
2024-05-10 S-8 FORM S-8 0001104659-24-059473 333-279287 24932169 33 57147
2024-05-09 10-Q 10-Q 0001558370-24-007646 001-36860 24931841 34 8921995 1 1
2024-05-09 8-K FORM 8-K 2.02,9.01 0001104659-24-059322 001-36860 24930468 34 295273 1 1
2024-05-01 ARS ARS 0001558370-24-006403 001-36860 24903959 34 7686203
2024-04-29 DEFA14A DEFA14A 0001558370-24-006150 001-36860 24892500 34 425889
2024-04-29 DEF 14A DEF 14A 0001558370-24-006148 001-36860 24892481 34 5193475 1 1
2024-04-17 4 OWNERSHIP DOCUMENT 0001104659-24-048429 9660
2024-04-17 4 OWNERSHIP DOCUMENT 0001104659-24-048428 9697
2024-04-17 4 OWNERSHIP DOCUMENT 0001104659-24-048427 9676
2024-04-03 8-K FORM 8-K 8.01,9.01 0001104659-24-043158 001-36860 24820042 34 3006480 1 1
2024-03-29 8-K FORM 8-K 5.02,5.03,9.01 0001104659-24-041200 001-36860 24804671 34 560206 1 1
2024-03-19 SC 13D/A SC 13D/A 0001104659-24-036221 005-85384 24765027 34 35808
2024-03-06 4 OWNERSHIP DOCUMENT 0001104659-24-031578 9697
2024-03-06 4 OWNERSHIP DOCUMENT 0001104659-24-031576 9657
2024-03-06 4 OWNERSHIP DOCUMENT 0001104659-24-031575 9676
2024-03-05 4 OWNERSHIP DOCUMENT 0001104659-24-031115 6266
2024-03-05 4 OWNERSHIP DOCUMENT 0001104659-24-031114 6434
2024-03-05 4 OWNERSHIP DOCUMENT 0001104659-24-031113 8474
2024-03-05 4 OWNERSHIP DOCUMENT 0001104659-24-031112 6415
2024-03-05 4 OWNERSHIP DOCUMENT 0001104659-24-031111 6402
2024-03-05 4 OWNERSHIP DOCUMENT 0001104659-24-031110 6513
2024-03-05 4 OWNERSHIP DOCUMENT 0001104659-24-031109 6376
2024-03-05 4 OWNERSHIP DOCUMENT 0001104659-24-031108 8513
2024-03-05 4 OWNERSHIP DOCUMENT 0001104659-24-031107 8496
2024-03-05 4 OWNERSHIP DOCUMENT 0001104659-24-031106 8521
2024-03-05 4 OWNERSHIP DOCUMENT 0001104659-24-031105 6432
2024-03-04 8-K FORM 8-K 8.01,9.01 0001104659-24-030249 001-36860 24712875 34 237260 1 1
2024-03-01 SC 13G SC 13G 0001193125-24-056337 005-85384 24712291 34 65014
2024-02-29 8-K FORM 8-K 8.01,9.01 0001104659-24-029057 001-36860 24698889 34 27528879 1 1
2024-02-28 10-K 10-K 0001558370-24-002036 001-36860 24696878 34 11643257 1 1
2024-02-28 8-K FORM 8-K 2.02,9.01 0001104659-24-028704 001-36860 24695201 34 289833 1 1
2024-02-22 8-K FORM 8-K 8.01,9.01 0001104659-24-026578 001-36860 24665751 34 220413 1 1
2024-02-21 424B5 424B5 0001104659-24-026070 333-272718 24660467 33 597157
2024-02-20 4 OWNERSHIP DOCUMENT 0001104659-24-025684 6513
2024-02-20 8-K FORM 8-K 1.01,8.01,9.01 0001104659-24-025617 001-36860 24655020 34 654530 1 1
2024-02-20 4 OWNERSHIP DOCUMENT 0001104659-24-025539 5093
2024-02-20 4 OWNERSHIP DOCUMENT 0001104659-24-025520 5916
2024-02-20 8-K FORM 8-K 2.02,8.01,9.01 0001104659-24-025082 001-36860 24650498 34 9055413 1 1
2024-02-14 SC 13G/A SC 13G/A 0001193125-24-036330 005-85384 24639004 34 63766
2024-02-14 SC 13G/A IOVANCE BIOTHERAPEUTICS, INC. 0000902664-24-001524 005-85384 24631952 34 77548
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-021231 005-85384 24628755 34 13418
2024-02-09 SC 13G/A SC 13G/A 0001193125-24-030378 005-85384 24616396 34 118143
2024-01-26 SC 13G/A us4622601007_012624.txt 0001086364-24-004378 005-85384 24565895 34 14008
2024-01-26 8-K FORM 8-K 8.01,9.01 0001104659-24-006804 001-36860 24563660 34 12907520 1 1
2024-01-25 SC 13G/A IovanceBiotherape.txt 0000093751-24-000225 005-85384 24559773 34 8852
2024-01-18 4 OWNERSHIP DOCUMENT 0001104659-24-004866 9424
2024-01-18 4 OWNERSHIP DOCUMENT 0001104659-24-004865 9463
2024-01-18 4 OWNERSHIP DOCUMENT 0001104659-24-004864 9442
2024-01-08 8-K FORM 8-K 8.01,9.01 0001104659-24-002290 001-36860 24520938 34 13429748 1 1
2023-12-27 8-K FORM 8-K 8.01,9.01 0001104659-23-129751 001-36860 231518614 34 226358 1 1
2023-11-21 UPLOAD filename1.pdf 0000000000-23-012764 40128
2023-11-17 CORRESP filename1.htm 0001104659-23-119611 310796
2023-11-07 10-Q 10-Q 0001558370-23-018029 001-36860 231385097 34 10108615 1 1
2023-11-07 8-K FORM 8-K 2.02,9.01 0001104659-23-115226 001-36860 231383661 34 305953 1 1
2023-10-27 SC 13D/A SC 13D/A 0001104659-23-112187 005-85384 231355894 34 33952
2023-10-26 UPLOAD filename1.pdf 0000000000-23-011765 44704
2023-10-18 4 OWNERSHIP DOCUMENT 0001104659-23-109942 9381
2023-10-18 4 OWNERSHIP DOCUMENT 0001104659-23-109941 9399
2023-10-18 4 OWNERSHIP DOCUMENT 0001104659-23-109940 9420
2023-09-19 4 OWNERSHIP DOCUMENT 0001104659-23-101954 5829
2023-09-15 4 OWNERSHIP DOCUMENT 0001104659-23-101299 5663
2023-09-15 8-K FORM 8-K 8.01,9.01 0001104659-23-100996 001-36860 231256728 34 224158 1 1
2023-08-18 8-K FORM 8-K 7.01,8.01,9.01 0001104659-23-093553 001-36860 231186701 34 14775824 1 1
2023-08-08 10-Q 10-Q 0001558370-23-013988 001-36860 231152534 34 9854847 1 1
2023-08-08 8-K FORM 8-K 2.02,9.01 0001104659-23-088821 001-36860 231151158 34 305609 1 1
2023-07-17 4 OWNERSHIP DOCUMENT 0001104659-23-081715 9380
2023-07-17 4 OWNERSHIP DOCUMENT 0001104659-23-081714 9419
2023-07-17 4 OWNERSHIP DOCUMENT 0001104659-23-081713 9398
2023-07-13 8-K FORM 8-K 8.01,9.01 0001104659-23-080770 001-36860 231087083 34 223607 1 1
2023-07-11 424B5 424B5 0001104659-23-080021 333-272718 231082732 33 664059
2023-07-11 8-K FORM 8-K 1.01,8.01,9.01 0001104659-23-080013 001-36860 231082632 34 659218 1 1
2023-07-10 424B5 424B5 0001104659-23-079713 333-272718 231080646 33 640974
2023-07-10 8-K FORM 8-K 2.02,8.01,9.01 0001104659-23-079684 001-36860 231080215 34 526525 1 1
2023-07-10 8-K FORM 8-K 8.01,9.01 0001104659-23-079364 001-36860 231078338 34 225386 1 1
2023-06-16 8-K FORM 8-K 1.01,1.02,9.01 0001104659-23-072308 001-36860 231022008 34 510543 1 1
2023-06-16 424B5 424B5 0001104659-23-072298 333-272718 231021843 33 700683
2023-06-16 S-3ASR S-3ASR 0001104659-23-072237 333-272718 231021183 33 948162
2023-06-12 S-8 FORM S-8 0001104659-23-070377 333-272602 231008570 33 216536
2023-06-12 S-8 FORM S-8 0001104659-23-070371 333-272601 231008557 33 165454
2023-06-08 4 OWNERSHIP DOCUMENT 0001104659-23-069509 6458
2023-06-08 4 OWNERSHIP DOCUMENT 0001104659-23-069508 6538
2023-06-08 4 OWNERSHIP DOCUMENT 0001104659-23-069507 6441
2023-06-08 4 OWNERSHIP DOCUMENT 0001104659-23-069506 6424
2023-06-08 4 OWNERSHIP DOCUMENT 0001104659-23-069505 6399
2023-06-08 4 OWNERSHIP DOCUMENT 0001104659-23-069504 6291
2023-06-06 8-K FORM 8-K 5.07 0001104659-23-068579 001-36860 23997005 34 213955 1 1
2023-06-02 8-K/A FORM 8-K/A 9.01 0001104659-23-067589 001-36860 23989328 34 14744778 1 1
2023-05-30 8-K FORM 8-K 8.01,9.01 0001104659-23-065591 001-36860 23971150 34 224867 1 1
2023-05-18 8-K FORM 8-K 2.01,9.01 0001104659-23-062282 001-36860 23936511 34 205045 1 1
2023-05-10 S-8 FORM S-8 0001104659-23-058489 333-271810 23907284 33 67819
2023-05-10 10-Q 10-Q 0001558370-23-009134 001-36860 23907014 34 7293236 1 1
2023-05-09 8-K FORM 8-K 2.02,9.01 0001104659-23-057722 001-36860 23901883 34 279190 1 1
2023-04-27 ARS ARS 0001558370-23-007111 001-36860 23858462 34 4196756
2023-04-26 DEFA14A DEFA14A 0001558370-23-006897 001-36860 23850834 34 430677
2023-04-26 DEF 14A DEF 14A 0001558370-23-006895 001-36860 23850811 34 4826723 1 1
2023-04-25 UPLOAD filename1.pdf 0000000000-23-004148 40069
2023-04-24 8-K FORM 8-K 5.02,9.01 0001104659-23-049060 001-36860 23840696 34 205236 1 1
2023-04-20 4 OWNERSHIP DOCUMENT 0001104659-23-047907 6286
2023-04-20 3 OWNERSHIP DOCUMENT 0001104659-23-047906 3121
2023-04-19 PRER14A PRER14A 0001558370-23-006233 001-36860 23830795 34 4645911 1 1
2023-04-18 4 OWNERSHIP DOCUMENT 0001104659-23-046844 9408
2023-04-18 4 OWNERSHIP DOCUMENT 0001104659-23-046843 9446
2023-04-18 4 OWNERSHIP DOCUMENT 0001104659-23-046842 9425
2023-04-14 PRE 14A PRE 14A 0001558370-23-005974 001-36860 23821891 34 4488826 1 1
2023-03-27 8-K FORM 8-K 8.01,9.01 0001104659-23-036858 001-36860 23761411 34 231020 1 1
2023-03-10 8-K FORM 8-K 7.01 0001104659-23-031225 001-36860 23724324 34 197374 1 1
2023-03-06 4 OWNERSHIP DOCUMENT 0001104659-23-029101 8729
2023-03-06 4 OWNERSHIP DOCUMENT 0001104659-23-029100 8715
2023-03-06 4 OWNERSHIP DOCUMENT 0001104659-23-029098 8698
2023-03-06 4 OWNERSHIP DOCUMENT 0001104659-23-029093 6005
2023-02-28 10-K 10-K 0001558370-23-002419 001-36860 23687212 34 11073716 1 1
2023-02-28 8-K FORM 8-K 2.02,9.01 0001104659-23-026699 001-36860 23685117 34 308869 1 1
2023-02-17 SC 13G IOVANCE BIOTHERAPEUTICS, INC. 0000902664-23-001919 005-85384 23643219 34 85635
2023-02-14 SC 13G/A SC 13G/A 0001193125-23-038730 005-85384 23627247 34 66614
2023-02-14 SC 13G/A IOVANCE BIOTHERAPEUTICS, INC. 0000902664-23-001668 005-85384 23623444 34 59157
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-016235 005-85384 23603484 34 13336
2023-02-06 SC 13G/A SEC SCHEDULE 13G 0000846087-23-000244 005-85384 23590295 34 33239
2023-02-03 SC 13G us4622601007_020323.txt 0001306550-23-007111 005-85384 23584729 34 13736
2023-02-02 SC 13G Iovance_Biotherapeutics_Inc.txt 0000093751-23-000088 005-85384 23579681 34 10696
2023-01-27 8-K/A FORM 8-K/A 9.01 0001104659-23-007585 001-36860 23564139 34 1551223 1 1
2023-01-23 8-K FORM 8-K 1.01,8.01,9.01 0001104659-23-005596 001-36860 23542564 34 247725 1 1
2023-01-19 4 OWNERSHIP DOCUMENT 0001104659-23-005048 9485
2023-01-19 4 OWNERSHIP DOCUMENT 0001104659-23-005046 9464
2023-01-19 4 OWNERSHIP DOCUMENT 0001104659-23-005045 9444
2023-01-13 SC 13D/A SC 13D/A 0001104659-23-003844 005-85384 23529140 34 39627
2023-01-11 8-K FORM 8-K 8.01,9.01 0001104659-23-002865 001-36860 23522460 34 9999938 1 1
2023-01-05 4 4 0001104659-23-001607 9394
2023-01-05 4 FORM 4 0001104659-23-001601 9378
2023-01-05 4 FORM 4 0001104659-23-001600 9630
2022-12-30 SC 13G SC 13G 0001193125-22-315432 005-85384 221502103 34 124241
2022-12-22 4 OWNERSHIP DOCUMENT 0001104659-22-129516 5797
2022-12-02 4 OWNERSHIP DOCUMENT 0001104659-22-124196 5632
2022-11-30 4 OWNERSHIP DOCUMENT 0001104659-22-123244 5797
2022-11-28 4 OWNERSHIP DOCUMENT 0001104659-22-122556 4806
2022-11-28 4 OWNERSHIP DOCUMENT 0001104659-22-122555 5797
2022-11-28 4 OWNERSHIP DOCUMENT 0001104659-22-122554 4774
2022-11-18 8-K FORM 8-K 1.01,1.02,9.01 0001104659-22-120391 001-36860 221402854 34 503887 1 1
2022-11-18 424B5 424B5 0001104659-22-120383 333-238724 221402795 33 855692
2022-11-18 8-K FORM 8-K 8.01,9.01 0001104659-22-120278 001-36860 221401986 34 6435087 1 1
2022-11-03 10-Q 10-Q 0001558370-22-016295 001-36860 221359139 34 8365207 1 1
2022-11-03 8-K FORM 8-K 2.02,9.01 0001104659-22-114414 001-36860 221357905 34 291935 1 1
2022-09-12 8-K FORM 8-K 8.01,9.01 0001104659-22-099284 001-36860 221239134 34 2029929 1 1
2022-08-29 8-K FORM 8-K 8.01,9.01 0001104659-22-095679 001-36860 221211872 34 9196300 1 1
2022-08-25 4 OWNERSHIP DOCUMENT 0001104659-22-094430 8151
2022-08-04 S-8 FORM S-8 0001104659-22-086237 333-266544 221137757 33 64626
2022-08-04 10-Q 10-Q 0001558370-22-012263 001-36860 221137396 34 8698073 1 1
2022-08-04 8-K FORM 8-K 2.02,9.01 0001104659-22-086115 001-36860 221136467 34 281930 1 1
2022-06-16 4 OWNERSHIP DOCUMENT 0001104659-22-071967 9690
2022-06-16 4 OWNERSHIP DOCUMENT 0001104659-22-071965 9916
2022-06-16 4 OWNERSHIP DOCUMENT 0001104659-22-071964 9664
2022-06-14 4 OWNERSHIP DOCUMENT 0001104659-22-071056 6426
2022-06-14 4 OWNERSHIP DOCUMENT 0001104659-22-071055 6507
2022-06-14 4 OWNERSHIP DOCUMENT 0001104659-22-071054 6410
2022-06-14 4 OWNERSHIP DOCUMENT 0001104659-22-071053 6393
2022-06-14 4 OWNERSHIP DOCUMENT 0001104659-22-071051 6368
2022-06-14 4 OWNERSHIP DOCUMENT 0001104659-22-071050 6257
2022-06-14 3 OWNERSHIP DOCUMENT 0001104659-22-071049 3123
2022-06-13 8-K FORM 8-K 5.02,5.07,8.01,9.01 0001104659-22-070604 001-36860 221012561 34 254088 1 1
2022-06-02 4 OWNERSHIP DOCUMENT 0001104659-22-067763 6903
2022-06-02 4 OWNERSHIP DOCUMENT 0001104659-22-067762 4806
2022-06-02 4 OWNERSHIP DOCUMENT 0001104659-22-067761 7389
2022-06-02 4 OWNERSHIP DOCUMENT 0001104659-22-067758 4797
2022-06-02 4 OWNERSHIP DOCUMENT 0001104659-22-067757 7317
2022-05-26 8-K FORM 8-K 8.01,9.01 0001104659-22-065357 001-36860 22971334 34 238789 1 1
2022-05-13 8-K FORM 8-K 8.01,9.01 0001104659-22-060471 001-36860 22924005 34 8410240 1 1
2022-05-05 10-Q 10-Q 0001558370-22-007449 001-36860 22897701 34 7270738 1 1
2022-05-05 8-K FORM 8-K 2.02,9.01 0001104659-22-056441 001-36860 22896139 34 270664 1 1
2022-04-29 8-K FORM 8-K 5.03,9.01 0001104659-22-053819 001-36860 22877406 34 527424 1 1
2022-04-27 DEFA14A DEFA14A 0001104659-22-051316 001-36860 22860930 34 3042776
2022-04-27 DEF 14A DEF 14A 0001104659-22-051293 001-36860 22860736 34 3615527
2022-04-05 8-K FORM 8-K 8.01,9.01 0001104659-22-042834 001-36860 22807873 34 223895 1 1
2022-03-11 S-8 FORM S-8 0001104659-22-032967 333-263503 22734078 33 66422
2022-02-24 SC 13G/A us4622601007_022422.txt 0000834237-22-008762 005-85384 22672773 34 12888
2022-02-24 10-K 10-K 0001558370-22-001976 001-36860 22672597 34 10869307 1 1
2022-02-24 8-K FORM 8-K 2.02,9.01 0001104659-22-026579 001-36860 22670892 34 303640 1 1
2022-02-14 SC 13G/A SC 13G/A 0001193125-22-041519 005-85384 22630833 34 67906
2022-02-14 SC 13G/A iova13gadec21.txt 0000080255-22-002106 005-85384 34 7355
2022-02-11 SC 13G/A IOVANCE BIOTHERAPEUTICS, INC. 0000902664-22-001520 005-85384 22617339 34 60895
2022-02-10 SC 13G/A SCHEDULE 13G/A 0001104659-22-017852 005-85384 22610072 34 13308
2022-02-04 SC 13G/A iova21a5.htm 0000038777-22-000041 005-85384 22592582 34 194718
2022-02-04 SC 13G SEC SCHEDULE 13G 0001678858-22-000304 005-85384 22591494 34 37595
2022-01-19 5 OWNERSHIP DOCUMENT 0001104659-22-005600 5159
2022-01-19 4 OWNERSHIP DOCUMENT 0001104659-22-005599 6071
2022-01-19 4 OWNERSHIP DOCUMENT 0001104659-22-005598 8708
2022-01-19 4 OWNERSHIP DOCUMENT 0001104659-22-005597 8691
2022-01-19 4 OWNERSHIP DOCUMENT 0001104659-22-005596 5998
2022-01-19 8-K FORM 8-K 5.02,9.01 0001104659-22-005513 001-36860 22539688 34 200078 1 1
2022-01-10 8-K 8-K 8.01,9.01 0001104659-22-002518 001-36860 22519797 34 220336 1 1
2021-11-04 10-Q 10-Q 0001558370-21-014670 001-36860 211381146 34 9164048 1 1
2021-11-04 8-K FORM 8-K 2.02,9.01 0001104659-21-134363 001-36860 211379895 34 305486 1 1
2021-09-23 S-8 S-8 0001558370-21-012707 333-259752 211273140 33 116104
2021-09-23 8-K 8-K 5.02,9.01 0001558370-21-012704 001-36860 211273040 34 467504 1 1
2021-08-05 10-Q 10-Q 0001558370-21-010617 001-36860 211149538 34 9602601 1 1
2021-08-05 8-K FORM 8-K 2.02,9.01 0001104659-21-100744 001-36860 211148127 34 294969 1 1
2021-07-01 4 OWNERSHIP DOCUMENT 0001104659-21-088253 5669
2021-07-01 4 OWNERSHIP DOCUMENT 0001104659-21-088252 5799
2021-07-01 4 OWNERSHIP DOCUMENT 0001104659-21-088251 5702
2021-07-01 4 OWNERSHIP DOCUMENT 0001104659-21-088249 5658
2021-07-01 4 OWNERSHIP DOCUMENT 0001104659-21-088245 5719
2021-06-29 8-K FORM 8-K 8.01,9.01 0001104659-21-086825 001-36860 211058166 34 1524997 1 1
2021-06-16 4 OWNERSHIP DOCUMENT 0001104659-21-082070 6008
2021-06-16 4 OWNERSHIP DOCUMENT 0001104659-21-082068 6000
2021-06-16 4 OWNERSHIP DOCUMENT 0001104659-21-082066 5983
2021-06-16 4 OWNERSHIP DOCUMENT 0001104659-21-082064 8420
2021-06-14 8-K FORM 8-K 5.02,5.07 0001104659-21-080846 001-36860 211015443 34 207340 1 1
2021-05-20 8-K FORM 8-K 8.01,9.01 0001104659-21-069880 001-36860 21944512 34 268001 1 1
2021-05-19 8-K FORM 8-K 5.02 0001104659-21-069172 001-36860 21939312 34 196391 1 1
2021-05-06 10-Q 10-Q 0001558370-21-006301 001-36860 21899112 34 7911727 1 1
2021-05-06 8-K FORM 8-K 1.01,2.02,9.01 0001104659-21-062388 001-36860 21897705 34 295213 1 1
2021-04-27 DEFA14A DEFA14A 0001104659-21-055715 001-36860 21860184 34 360706
2021-04-27 DEF 14A DEF 14A 0001104659-21-055704 001-36860 21860121 34 917155
2021-04-26 8-K FORM 8-K 5.03,9.01 0001104659-21-054582 001-36860 21850937 34 468283 1 1
2021-04-12 8-K FORM 8-K 8.01,9.01 0001104659-21-049327 001-36860 21820861 34 10007681 1 1
2021-03-16 4 OWNERSHIP DOCUMENT 0001104659-21-037316 5968
2021-03-16 3 OWNERSHIP DOCUMENT 0001104659-21-037315 3273
2021-03-15 8-K FORM 8-K 5.02,8.01,9.01 0001104659-21-036244 001-36860 21741599 34 233882 1 1
2021-03-12 8-K FORM 8-K 4.01,9.01 0001104659-21-035671 001-36860 21738511 34 224661 1 1
2021-03-11 8-K FORM 8-K 5.02 0001104659-21-035027 001-36860 21733713 34 199087 1 1
2021-02-25 10-K 10-K 0001558370-21-001858 001-36860 21681670 34 11936722 1 1

Latest XBRL company facts

One latest value per concept from companyfacts (405 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 462.66M 2026-10-27 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
dei EntityPublicFloat Entity Public Float USD 534.80M 2025-06-30 2025 FY 10-K 2026-02-24 0001104659-26-018899
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 684,323 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001104659-26-050458
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 1.29M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001104659-26-050458
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 124.75 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001104659-26-050458
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 5.88 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001104659-26-050458
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 21.64M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap AccountsPayableRelatedPartiesCurrent Accounts Payable, Related Parties, Current USD 86,000 2016-03-31 2016 Q1 10-Q 2016-05-09 0001144204-16-099858
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 106.99M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 4.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap AccruedEmployeeBenefitsCurrent Accrued Employee Benefits, Current USD 36.78M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 81.69M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 81.69M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 1.20M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap AccruedProfessionalFeesCurrentAndNoncurrent Accrued Professional Fees USD 600,000 2024-06-30 2024 Q3 10-Q 2024-11-07 0001558370-24-014905
us-gaap AccruedRentCurrent Accrued Rent, Current USD 124,000 2018-12-31 2019 FY 10-K 2020-02-25 0001104659-20-024830
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 60.12M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 13.85M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 3.72B 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 87.61M 2014-09-30 2014 Q3 10-Q 2014-11-13 0001513160-14-000060
us-gaap AdjustmentsToAdditionalPaidInCapitalMarkToMarket Adjustments to Additional Paid in Capital, Fair Value USD 6.07M 2016-01-01 2016-06-30 2016 Q2 10-Q 2016-08-09 0001144204-16-117596
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD 49.45M 2016-01-01 2016-12-31 2018 FY 10-K 2019-02-28 0001144204-19-010702
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 35.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition USD 1.07M 2016-01-01 2016-06-30 2016 Q2 10-Q 2016-08-09 0001144204-16-117596
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 384,265 2011-01-01 2011-06-30 2011 Q2 10-Q/A 2011-09-01 0001144204-11-050977
us-gaap AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net USD -2.65M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-03 0001558370-22-016295
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 100,000 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-05 0001558370-20-012946
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 6.01M 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-24 0001558370-22-001976
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 2.87M 2007-09-17 2014-03-31 2014 Q1 10-Q 2014-05-14 0001354488-14-002559
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 17.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 29.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap AreaOfLand Area of Land sqft 8,733 2016-08-04 2016 FY 10-K 2017-03-09 0001144204-17-013535
us-gaap Assets Assets USD 991.21M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap AssetsCurrent Assets, Current USD 549.63M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 638.68M 2021-09-30 2021 Q3 10-Q 2021-11-04 0001558370-21-014670
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 29,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 217,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 339.80M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap AvailableForSaleDebtSecuritiesGrossUnrealizedLoss Debt Securities, Available-for-sale, Unrealized Loss USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap AvailableForSaleSecurities Available-for-sale Securities USD 611.26M 2020-06-30 2020 Q2 10-Q 2020-08-06 0001104659-20-091526
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax USD 326,000 2020-06-30 2020 Q2 10-Q 2020-08-06 0001104659-20-091526
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax USD 9,000 2020-06-30 2020 Q2 10-Q 2020-08-06 0001104659-20-091526
us-gaap AvailableForSaleSecuritiesAmortizedCost Available-for-sale Securities, Amortized Cost Basis USD 611.05M 2020-06-30 2020 Q2 10-Q 2020-08-06 0001104659-20-091526
us-gaap AvailableForSaleSecuritiesCurrent Available-for-sale Securities, Current USD 193.11M 2020-03-31 2020 Q1 10-Q 2020-05-05 0001104659-20-056994
us-gaap AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost USD 373.37M 2022-12-31 2022 FY 10-K 2023-02-28 0001558370-23-002419
us-gaap AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value USD 372.47M 2022-12-31 2022 FY 10-K 2023-02-28 0001558370-23-002419
us-gaap AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value USD 372.47M 2022-12-31 2022 FY 10-K 2023-02-28 0001558370-23-002419
us-gaap AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost USD 373.37M 2022-12-31 2022 FY 10-K 2023-02-28 0001558370-23-002419
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 339.61M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 318.39M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap AvailableForSaleSecuritiesDebtSecuritiesNoncurrent Debt Securities, Available-for-sale, Noncurrent USD 91.59M 2021-12-31 2022 FY 10-K 2023-02-28 0001558370-23-002419
us-gaap BankOverdrafts Bank Overdrafts USD 17,619 2012-03-31 2012 Q1 10-Q 2012-05-15 0001513160-12-000038
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 683,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-09 0001558370-24-007646
us-gaap Cash Cash USD 17.19M 2014-09-30 2014 Q3 10-Q 2014-11-13 0001513160-14-000060
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 57.93M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -28.06M 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-07 0001144204-19-024279
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 610.20M 2021-03-31 2021 Q1 10-Q 2021-05-06 0001558370-21-006301
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 63.95M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 311.75M 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-10 0001558370-23-009134
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -105.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 21.22M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 6.95M 2016-06-30 2016 Q2 10-Q 2016-08-09 0001144204-16-117596
us-gaap CommitmentsAndContingencies Commitments and Contingencies USD 0 2014-09-30 2014 Q3 10-Q 2014-11-13 0001513160-14-000060
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 650.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 462.54M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 462.54M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap CommonStockSharesSubscribedButUnissued Common Stock, Shares Subscribed but Unissued shares 400,000 2013-09-30 2013 Q3 10-Q 2013-11-14 0001513160-13-000069
us-gaap CommonStockValue Common Stock, Value, Issued USD 19,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -151.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap ContractualObligation Contractual Obligation USD 31.60M 2018-12-31 2018 FY 10-K 2019-02-28 0001144204-19-010702
us-gaap ContractualObligationDueInFifthYear Contractual Obligation, to be Paid, Year Five USD 0 2018-12-31 2018 FY 10-K 2019-02-28 0001144204-19-010702
us-gaap ContractualObligationDueInFourthYear Contractual Obligation, to be Paid, Year Four USD 581,000 2018-12-31 2018 FY 10-K 2019-02-28 0001144204-19-010702
us-gaap ContractualObligationDueInNextTwelveMonths Contractual Obligation, to be Paid, Year One USD 19.36M 2018-12-31 2018 FY 10-K 2019-02-28 0001144204-19-010702
us-gaap ContractualObligationDueInSecondYear Contractual Obligation, to be Paid, Year Two USD 8.91M 2018-12-31 2018 FY 10-K 2019-02-28 0001144204-19-010702
us-gaap ContractualObligationDueInThirdYear Contractual Obligation, to be Paid, Year Three USD 2.74M 2018-12-31 2018 FY 10-K 2019-02-28 0001144204-19-010702
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 1,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap ConversionOfStockSharesConverted1 Conversion of Stock, Shares Converted shares 1.52M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-06 0001144204-18-057663
us-gaap ConversionOfStockSharesIssued1 Conversion of Stock, Shares Issued shares 1.00M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-06 0001144204-15-063327
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 0 2013-12-31 2013 FY 10-K 2014-03-28 0001513160-14-000023
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 3.42M 2016-09-30 2016 Q3 10-Q 2016-11-04 0001144204-16-131686
us-gaap CostOfRevenue Cost of Revenue USD 134.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap CostsAndExpenses Costs and Expenses USD 449.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption Cumulative Effect of New Accounting Principle in Period of Adoption (Deprecated 2020-01-31) USD 300,000 2019-01-01 2019 Q3 10-Q 2019-11-04 0001104659-19-059564
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001558370-21-001858
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001558370-21-001858
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-11 0001144204-16-087506
us-gaap DebtConversionOriginalDebtAmount1 Debt Conversion, Original Debt, Amount USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-11 0001144204-16-087506
us-gaap DebtInstrumentConvertibleBeneficialConversionFeature Debt Instrument, Convertible, Beneficial Conversion Feature USD 177,258 2011-01-01 2011-12-31 2012 FY 10-K 2013-09-23 0001513160-13-000055
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 1 2013-05-22 2014 FY 10-K 2015-03-16 0001144204-15-016315
us-gaap DebtInstrumentDecreaseForgiveness Debt Instrument, Decrease, Forgiveness USD 18,137 2007-09-17 2014-03-31 2014 Q1 10-Q 2014-05-14 0001354488-14-002559
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 497,888 2012-06-30 2012 Q2 10-Q/A 2012-09-10 0001513160-12-000063
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions Securities 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD -59.93M 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001558370-21-001858
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD -1.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 30.01M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 230,000 2018-12-31 2018 FY 10-K 2019-02-28 0001144204-19-010702
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD -760,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001558370-21-001858
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 706.48M 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-018899
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2022-12-31 2022 FY 10-K 2023-02-28 0001558370-23-002419
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 18.98M 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-018899
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 416.15M 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-018899
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 2.22M 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-018899
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 65.18M 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-018899
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 41.27M 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-018899
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 18.92M 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-018899
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 687.50M 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-018899
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 31.83M 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-018899
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets Deferred Tax Liabilities, Intangible Assets USD 17.30M 2023-12-31 2023 FY 10-K 2024-02-28 0001558370-24-002036
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 179,000 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-018899
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 6.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-018899
us-gaap DepositsAssetsCurrent Deposits Assets, Current USD 9,391 2011-12-31 2011 FY 10-K 2012-03-30 0001144204-12-018611
us-gaap DepositsAssetsNoncurrent Deposits Assets, Noncurrent USD 16,000 2011-12-31 2012 FY 10-K 2013-09-23 0001513160-13-000055
us-gaap Depreciation Depreciation USD 5.70M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-08 0001558370-23-013988
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 27.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 10.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD 10.00M 2007-09-17 2014-03-31 2014 Q1 10-Q 2014-05-14 0001354488-14-002559
us-gaap DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net USD 10.00M 2007-09-17 2014-03-31 2014 Q1 10-Q 2014-05-14 0001354488-14-002559
us-gaap DerivativeLiabilities Derivative Liability USD 7.94M 2011-12-31 2012 FY 10-K 2013-09-23 0001513160-13-000055
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 7.94M 2011-12-31 2012 FY 10-K 2013-09-23 0001513160-13-000055
us-gaap DueFromRelatedPartiesCurrent Due from Related Parties, Current USD 50,000 2011-09-30 2011 Q3 10-Q 2011-11-21 0001144204-11-066214
us-gaap DueToOfficersOrStockholdersCurrentAndNoncurrent Due to Officers or Stockholders USD 85,500 2014-12-31 2014 FY 10-K 2015-03-16 0001144204-15-016315
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 300,000 2018-06-30 2018 Q2 10-Q 2018-08-07 0001144204-18-042241
us-gaap DueToRelatedPartiesCurrentAndNoncurrent Due to Related Parties USD 208,322 2014-09-30 2014 Q3 10-Q 2014-11-13 0001513160-14-000060
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.34 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.51 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-06 0001558370-21-006301
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.34 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.01 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.15 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-018899
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0.23 2017-01-01 2017-12-31 2019 FY 10-K 2020-02-25 0001104659-20-024830
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-018899
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.05 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-018899
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.02 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-24 0001104659-26-018899
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.05 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-28 0001513160-14-000023
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure 0.02 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0001558370-25-001834
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-018899
us-gaap EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal Effective Income Tax Rate Reconciliation, Tax Settlement, State and Local, Percent pure 0.1 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-24 0001104659-26-018899
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD -326,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount Share-based Payment Arrangement, Amount Capitalized USD 1.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 43.40M 2019-09-30 2019 Q3 10-Q 2019-11-04 0001104659-19-059564
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 10.90M 2017-12-31 2017 FY 10-K 2018-03-12 0001144204-18-014151
us-gaap FairValueAssumptionsExpectedDividendRate Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) pure 0 2012-01-01 2012-12-31 2012 FY 10-K 2013-09-23 0001513160-13-000055
us-gaap FairValueAssumptionsExpectedVolatilityRate Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) pure 1.29 2012-01-01 2012-12-31 2012 FY 10-K 2013-09-23 0001513160-13-000055
us-gaap FairValueAssumptionsRiskFreeInterestRate Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) pure 0.009 2012-01-01 2012-12-31 2012 FY 10-K 2013-09-23 0001513160-13-000055
us-gaap FairValueOfAssetsAcquired Fair Value of Assets Acquired USD 222.64M 2023-01-01 2023-12-31 2025 FY 10-K 2026-02-24 0001104659-26-018899
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 72.19M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap FinitelivedIntangibleAssetsAcquired1 Finite-lived Intangible Assets Acquired GBP 13.90M 2024-01-01 2024-03-31 2026 Q1 10-Q 2026-05-07 0001104659-26-056778
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 22.50M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 5.60M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 22.80M 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-018899
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 22.50M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 22.50M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 22.50M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 331.40M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 259.21M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD -497,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD -397,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-02-28 0001558370-24-002036
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD -672,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -44,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-018899
us-gaap GainLossOnTerminationOfLease Gain (Loss) on Termination of Lease USD 5.57M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-24 0001104659-26-018899
us-gaap GainLossRelatedToLitigationSettlement Gain (Loss) Related to Litigation Settlement USD 336,000 2019-01-01 2019-12-31 2021 FY 10-K 2022-02-24 0001558370-22-001976
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 1.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 116.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain USD 0 2018-09-30 2018 Q3 10-Q 2018-11-06 0001144204-18-057663
us-gaap HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss USD 120,000 2018-09-30 2018 Q3 10-Q 2018-11-06 0001144204-18-057663
us-gaap HeldToMaturitySecuritiesCurrent Debt Securities, Held-to-maturity, Current USD 178.99M 2018-09-30 2018 Q3 10-Q 2018-11-06 0001144204-18-057663
us-gaap ImpairmentOfIntangibleAssetsExcludingGoodwill Impairment of Intangible Assets (Excluding Goodwill) USD 160,036 2007-09-17 2014-03-31 2014 Q1 10-Q 2014-05-14 0001354488-14-002559
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 7.36M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0001558370-25-001834
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -150.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-018899
us-gaap IncomeTaxExaminationPenaltiesAndInterestExpense Income Tax Examination, Penalties and Interest Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-018899
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD -1.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 58.54M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-018899
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -82.54M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-018899
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 1.78M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-018899
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 19.04M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-018899
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 1.74M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-018899
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 1.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 2.29M 2007-12-17 2013-12-31 2013 FY 10-K 2014-03-28 0001513160-14-000023
us-gaap IncreaseDecreaseInAccountsPayableRelatedParties Increase (Decrease) in Accounts Payable, Related Parties USD -253,231 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-16 0001144204-15-016315
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 24.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -25.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap IncreaseDecreaseInDeferredIncomeTaxes Increase (Decrease) in Deferred Income Taxes USD 20.80M 2017-10-01 2017-12-31 2018 FY 10-K 2019-02-28 0001144204-19-010702
us-gaap IncreaseDecreaseInDemandDeposits Increase (Decrease) in Demand Deposits USD -15,074 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-13 0001513160-14-000060
us-gaap IncreaseDecreaseInDepositsOutstanding Increase (Decrease) in Deposits Outstanding USD -9,391 2007-09-17 2011-12-31 2011 FY 10-K 2012-03-30 0001144204-12-018611
us-gaap IncreaseDecreaseInDueToOfficersAndStockholders Increase (Decrease) in Due to Officers and Stockholders USD 18,137 2007-09-17 2014-03-31 2014 Q1 10-Q 2014-05-14 0001354488-14-002559
us-gaap IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) USD 10.00M 2007-09-17 2013-03-31 2013 Q1 10-Q 2013-10-23 0001513160-13-000061
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 4.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -3.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities Increase (Decrease) in Other Accounts Payable and Accrued Liabilities USD 1.29M 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-04 0001144204-16-131686
us-gaap IncreaseDecreaseInOtherAccruedLiabilities Increase (Decrease) in Other Accrued Liabilities USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-16 0001144204-15-016315
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD 19.95M 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-11 0001144204-16-087506
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 3.63M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-12 0001144204-18-014151
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -16,000 2007-09-17 2011-12-31 2011 FY 10-K 2012-03-30 0001144204-12-018611
us-gaap IncreaseDecreaseInOutstandingChecksOperatingActivities Increase (Decrease) in Outstanding Checks, Operating Activities USD 17,619 2007-09-17 2012-03-31 2012 Q1 10-Q 2012-05-15 0001513160-12-000038
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -4.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD -4,473 2007-09-17 2011-12-31 2011 FY 10-K 2012-03-30 0001144204-12-018611
us-gaap InterestExpense Interest Expense USD -5,660 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-16 0001144204-15-016315
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 511,000 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-04 0001144204-16-131686
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 0 2016-01-01 2016-06-30 2016 Q2 10-Q 2016-08-09 0001144204-16-117596
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-28 0001144204-19-010702
us-gaap InterestPayableCurrent Interest Payable, Current USD 476,566 2014-09-30 2014 Q3 10-Q 2014-11-13 0001513160-14-000060
us-gaap InventoryFinishedGoodsNetOfReserves Inventory, Finished Goods, Net of Reserves USD 20.37M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap InventoryNet Inventory, Net USD 55.22M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap InventoryNoncurrent Inventory, Noncurrent USD 4.30M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap InventoryRawMaterialsNetOfReserves Inventory, Raw Materials, Net of Reserves USD 33.12M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap InventoryWorkInProcessNetOfReserves Inventory, Work in Process, Net of Reserves USD 6.02M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap InventoryWriteDown Inventory Write-down USD 2.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap InvestmentIncomeAmortizationOfPremium Investment Income, Amortization of Premium USD -69,000 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-04 0001144204-16-131686
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 6.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap InvestmentOwnedAtFairValue Investment Owned, at Fair Value USD 179.26M 2018-09-30 2018 Q3 10-Q 2018-11-06 0001144204-18-057663
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 1.07M 2016-01-01 2016-06-30 2016 Q2 10-Q 2016-08-09 0001144204-16-117596
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 1.00M 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-28 0001144204-19-010702
us-gaap LeaseCost Lease, Cost USD 7.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap LegalFees Legal Fees USD 400,000 2022-09-30 2022 Q3 10-Q 2022-11-03 0001558370-22-016295
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 74.98M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 53.39M 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-018899
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 5.47M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 4.61M 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-018899
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 4.61M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 4.84M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 5.02M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 1.65M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 29.77M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap LettersOfCreditOutstandingAmount Letters of Credit Outstanding, Amount USD 60.00M 2023-09-30 2023 Q3 10-Q 2023-11-07 0001558370-23-018029
us-gaap Liabilities Liabilities USD 178.55M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 991.21M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap LiabilitiesCurrent Liabilities, Current USD 105.77M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 72.78M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap LicenseCosts License Costs (Deprecated 2018-01-31) USD 600,000 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-04 0001144204-16-131686
us-gaap LongTermInvestments Long-term Investments USD 91.59M 2021-12-31 2022 FY 10-K 2023-02-28 0001558370-23-002419
us-gaap LongTermNotesPayable Notes Payable, Noncurrent USD 1.00M 2024-12-31 2025 FY 10-K 2026-02-24 0001104659-26-018899
us-gaap LossContingencyDamagesSoughtValue Loss Contingency, Damages Sought, Value USD 500,000 2016-04-08 2023 Q3 10-Q 2023-11-07 0001558370-23-018029
us-gaap LossContingencyNewClaimsFiledNumber Loss Contingency, New Claims Filed, Number Item 2 2025-05-15 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap MoneyMarketFundsAtCarryingValue Money Market Funds, at Carrying Value USD 19.74M 2016-06-30 2016 Q2 10-Q 2016-08-09 0001144204-16-117596
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 229.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD -265,000 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-03 0001144204-17-040380
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -197.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD 44.13M 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-03 0001144204-17-040380
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -137.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD 57.70M 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-02 0001144204-17-055799
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -148.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -123.58M 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-28 0001144204-19-010702
us-gaap NoncashMergerRelatedCosts Noncash Merger Related Costs USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-11 0001144204-16-087506
us-gaap NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1 Noncash or Part Noncash Acquisition, Intangible Assets Acquired USD 17.50M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-24 0001104659-26-018899
us-gaap NotesPayable Notes Payable USD 9.27M 2013-05-22 2014 FY 10-K 2015-03-16 0001144204-15-016315
us-gaap NotesPayableCurrent Notes Payable, Current USD 1.00M 2025-12-31 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap OperatingCostsAndExpenses Operating Costs and Expenses USD 7.26M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-06 0001144204-15-063327
us-gaap OperatingExpenses Operating Expenses USD 110.86M 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-10 0001558370-23-009134
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -156.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap OperatingLeaseCost Operating Lease, Cost USD 6.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 45.21M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 2.44M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 42.77M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap OperatingLeasePayments Operating Lease, Payments USD 6.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 42.56M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 3.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 8.33M 2020-06-30 2020 Q2 10-Q 2020-08-06 0001104659-20-091526
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 501,000 2018-06-30 2018 Q2 10-Q 2018-08-07 0001144204-18-042241
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 273,000 2020-06-30 2020 Q2 10-Q 2020-08-06 0001104659-20-091526
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 265,000 2020-06-30 2020 Q2 10-Q 2020-08-06 0001104659-20-091526
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 338,000 2020-06-30 2020 Q2 10-Q 2020-08-06 0001104659-20-091526
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 4.14M 2020-06-30 2020 Q2 10-Q 2020-08-06 0001104659-20-091526
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 115,000 2020-06-30 2020 Q2 10-Q 2020-08-06 0001104659-20-091526
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 3.19M 2020-06-30 2020 Q2 10-Q 2020-08-06 0001104659-20-091526
us-gaap OperatingLeasesOfLesseeContingentRentalsBasisSpreadOnVariableRate Operating Leases of Lessee, Contingent Rentals, Basis Spread on Variable Rate pure 0.03 2018-10-19 2020 FY 10-K 2021-02-25 0001558370-21-001858
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.075 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 15.20M 2024-12-31 2024 FY 10-K 2025-02-27 0001558370-25-001834
us-gaap OriginationOfNotesReceivableFromRelatedParties Origination of Notes Receivable from Related Parties USD 0 2007-09-17 2012-09-30 2012 Q3 10-Q 2013-01-25 0001513160-13-000022
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 4.70M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 4.48M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD -2.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -251,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 11.71M 2020-12-31 2021 FY 10-K 2022-02-24 0001558370-22-001976
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 200,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-11 0001144204-16-087506
us-gaap OtherPreferredStockDividendsAndAdjustments Other Preferred Stock Dividends and Adjustments USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-28 0001144204-19-010702
us-gaap OtherSignificantNoncashTransactionValueOfConsiderationReceived1 Other Significant Noncash Transaction, Value of Consideration Received USD -19,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-09 0001144204-17-013535
us-gaap PaymentsForProceedsFromShortTermInvestments Payments for (Proceeds from) Short-term Investments USD -201,000 2016-01-01 2016-06-30 2016 Q2 10-Q 2016-08-09 0001144204-16-117596
us-gaap PaymentsForRestructuring Payments for Restructuring USD 3.80M 2025-07-01 2025-09-30 2025 Q3 10-Q 2025-11-06 0001104659-25-107470
us-gaap PaymentsForTenantImprovements Payments for Tenant Improvements USD 8.20M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0001558370-25-001834
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 7.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap PaymentsToAcquireAvailableForSaleSecurities Payments to Acquire Available-for-sale Securities USD 534.72M 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-08-06 0001104659-20-091526
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 372.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 52.57M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-08 0001558370-24-011641
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 100,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 16.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 10.03M 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-09 0001144204-16-099858
us-gaap PaymentsToEmployees Payments to Employees USD 84,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-16 0001144204-15-016315
us-gaap PaymentsToFundLongtermLoansToRelatedParties Payments to Fund Long-term Loans to Related Parties USD 50,000 2007-09-17 2014-03-31 2014 Q1 10-Q 2014-05-14 0001354488-14-002559
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2016-03-31 2016 Q1 10-Q 2016-05-09 0001144204-16-099858
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 50.00M 2019-12-31 2019 FY 10-K 2020-02-25 0001104659-20-024830
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 1,694 2016-03-31 2016 Q1 10-Q 2016-05-09 0001144204-16-099858
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 1,694 2016-03-31 2016 Q1 10-Q 2016-05-09 0001144204-16-099858
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2016-03-31 2016 Q1 10-Q 2016-05-09 0001144204-16-099858
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 11.11M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 41,141 2014-09-30 2014 Q3 10-Q 2014-11-13 0001513160-14-000060
us-gaap ProceedsFromBankDebt Proceeds from Bank Debt USD 17,619 2012-01-01 2012-03-31 2013 Q1 10-Q 2013-10-23 0001513160-13-000061
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-11 0001144204-16-087506
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 32.20M 2014-01-01 2014-12-31 2015 FY 10-K 2016-03-11 0001144204-16-087506
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 235.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 1.00M 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-28 0001558370-24-002036
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-11 0001144204-16-087506
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 100.00M 2016-06-01 2016-06-30 2016 Q3 10-Q 2016-11-04 0001144204-16-131686
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised USD 2.41M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0001558370-24-002036
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 95.69M 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-04 0001144204-16-131686
us-gaap ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities Proceeds from Sale and Maturity of Debt Securities, Available-for-sale USD 192.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 831,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 15.75M 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-25 0001558370-21-001858
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -12.03M 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-16 0001144204-15-016315
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 189.43M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 129.31M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap PurchaseObligation Purchase Obligation USD 9.80M 2016-12-31 2016 FY 10-K 2017-03-09 0001144204-17-013535
us-gaap PurchaseObligationDueInSecondYear Purchase Obligation, to be Paid, Year Two USD 7.20M 2024-03-31 2024 Q1 10-Q 2024-05-09 0001558370-24-007646
us-gaap PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear Purchase Obligation, to be Paid, Remainder of Fiscal Year USD 9.10M 2026-03-31 2026 Q1 10-Q 2026-05-07 0001104659-26-056778
us-gaap RecordedUnconditionalPurchaseObligation Recorded Unconditional Purchase Obligation USD 5.98M 2015-09-30 2015 Q3 10-Q 2015-11-06 0001144204-15-063327
us-gaap RecordedUnconditionalPurchaseObligationDueInSecondYear Recorded Unconditional Purchase Obligation, to be Paid, Year Two USD 2.87M 2015-09-30 2015 Q3 10-Q 2015-11-06 0001144204-15-063327
us-gaap RecordedUnconditionalPurchaseObligationDueWithinOneYear Recorded Unconditional Purchase Obligation, to be Paid, Year One USD 3.10M 2015-09-30 2015 Q3 10-Q 2015-11-06 0001144204-15-063327
us-gaap RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty Related Party Transaction, Expenses from Transactions with Related Party USD 22,412 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-28 0001513160-14-000023
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD -50,000 2007-09-17 2011-09-30 2011 Q3 10-Q 2011-11-21 0001144204-11-066214
us-gaap ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross Research and Development Arrangement, Contract to Perform for Others, Costs Incurred, Gross USD 5.30M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0001558370-24-002036
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 170.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap RestrictedCash Restricted Cash USD 6.02M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 2.32M 2011-09-30 2011 Q3 10-Q 2011-11-21 0001144204-11-066214
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 559,000 2025-03-31 2025 Q1 10-Q 2025-05-08 0001558370-25-007009
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 6.02M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap RestructuringCharges Restructuring Charges USD 5.14M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -2.92B 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 292.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap Revenues Revenues USD 0 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-07 0001144204-19-024279
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 2.31M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-24 0001104659-26-018899
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 9.97 2018-10-17 2020 FY 10-K 2021-02-25 0001558370-21-001858
us-gaap SalesRevenueGoodsNet Sales Revenue, Goods, Net (Deprecated 2018-01-31) USD 0 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-13 0001513160-14-000060
us-gaap SecuredDebtCurrent Secured Debt, Current USD 0 2013-12-31 2013 FY 10-K 2014-03-28 0001513160-14-000023
us-gaap SecurityDeposit Security Deposit USD 600,000 2023-12-31 2023 FY 10-K 2024-02-28 0001558370-24-002036
us-gaap SeniorNotes Senior Notes USD 250,000 2012-06-30 2012 Q2 10-Q/A 2012-09-10 0001513160-12-000063
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 34.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1 Share-based Payment Arrangement, Expensed and Capitalized, Amount USD 34.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested USD 93.10M 2024-09-30 2024 Q3 10-Q 2024-11-07 0001558370-24-014905
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-28 0001144204-19-010702
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 7.02 2016-01-01 2016-12-31 2018 FY 10-K 2019-02-28 0001144204-19-010702
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-28 0001144204-19-010702
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 0 2017-01-01 2017-12-31 2018 FY 10-K 2019-02-28 0001144204-19-010702
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 11,458 2020-03-31 2020 Q1 10-Q 2020-05-05 0001104659-20-056994
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 6.48 2016-12-31 2018 FY 10-K 2019-02-28 0001144204-19-010702
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 137,500 2016-06-01 2020 FY 10-K 2021-02-25 0001558370-21-001858
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 6.48 2017-01-01 2017-12-31 2018 FY 10-K 2019-02-28 0001144204-19-010702
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments USD 0 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-28 0001513160-14-000023
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-06 0001558370-21-006301
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.704 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-06 0001558370-21-006301
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.004 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-06 0001558370-21-006301
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 13.85M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 16.71 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 1.10M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-24 0001104659-26-018899
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 2.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 14.87 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 1.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 5.29 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 83.30M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 17.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 14.57 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 52.90M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 83.30M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 17.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 14.57 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value (Deprecated 2013-01-31) USD 87,386 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-10-23 0001513160-13-000061
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 7.68 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 6.96 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap SharePrice Share Price USD/shares 8 2015-03-31 2015 FY 10-K 2016-03-11 0001144204-16-087506
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 9.15 2024-02-22 2025 FY 10-K 2026-02-24 0001104659-26-018899
us-gaap ShortTermInvestments Short-term Investments USD 318.39M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 190,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 812.66M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap StockIssued1 Stock Issued USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-11 0001144204-16-087506
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 23.01M 2024-02-22 2025 FY 10-K 2026-02-24 0001104659-26-018899
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 172,413 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 16.66M 2013-01-01 2013-12-31 2015 FY 10-K 2016-03-11 0001144204-16-087506
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 0 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-07 0001558370-25-010807
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 861,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap StockIssuedDuringPeriodValueIssuedForCash Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) USD 1.24M 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-16 0001144204-15-016315
us-gaap StockIssuedDuringPeriodValueIssuedForNoncashConsiderations Development Stage Entities, Stock Issued, Value, Issued for Noncash Consideration (Deprecated 2015-01-31) USD 122,734 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-16 0001144204-15-016315
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 1.77M 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-12 0001144204-18-014151
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 235.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 306.31M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-018899
us-gaap StockIssuedDuringPeriodValuePurchaseOfAssets Stock Issued During Period, Value, Purchase of Assets USD 217,408 2010-01-01 2010-12-31 2013 FY 10-K 2014-03-28 0001513160-14-000023
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 0 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-06 0001104659-25-107470
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 50,000 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-15 0001513160-12-000038
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 831,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap StockOptionPlanExpense Stock or Unit Option Plan Expense USD 6.07M 2016-01-01 2016-06-30 2016 Q2 10-Q 2016-08-09 0001144204-16-117596
us-gaap StockRepurchasedAndRetiredDuringPeriodShares Stock Repurchased and Retired During Period, Shares shares 32,500 2019-01-16 2020 FY 10-K 2021-02-25 0001558370-21-001858
us-gaap TaxCreditCarryforwardAmount Tax Credit Carryforward, Amount USD 45.00M 2015-12-31 2015 FY 10-K 2016-03-11 0001144204-16-087506
us-gaap TradingSecuritiesCost Trading Securities, Cost USD 90.37M 2016-12-31 2017 FY 10-K 2018-03-12 0001144204-18-014151
us-gaap TradingSecuritiesUnrealizedHoldingGain Trading Securities, Unrealized Holding Gain USD 61,000 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-12 0001144204-18-014151
us-gaap TradingSecuritiesUnrealizedHoldingLoss Trading Securities, Unrealized Holding Loss USD 32,000 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-12 0001144204-18-014151
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD 251,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 28.80M 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-018899
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 4.23M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-018899
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 3.17M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-018899
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 129.90M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-018899
us-gaap VariableLeaseCost Variable Lease, Cost USD 1.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 442.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 150,571 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-05 0001558370-21-010617
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 442.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448809

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →